Many of your patients are undergoing complicated, multiphase cancer treatments. We all need a basic understanding of what they are facing. Medscape Internal Medicine
Author: Medscape
Leaving Your Legacy Via Death Bots? Ethicist Shares Concerns
Ethicist Art Caplan discusses using artificial intelligence to leave a digital legacy after death. Medscape Business of Medicine
Low-Dose Steroids Reduce Glaucoma Risk in Kids
Low-dose glucocorticoid treatment after cataract surgery was associated with a reduced risk for glaucoma in children with longer axial length. Medscape Medical News
Pickleball Rx: Serving Up Advice for Patients and Players
Falls are always a risk for athletes, particularly older people. But they can be prevented. Medscape Family Medicine
Research Promises Better Diabetic Retinopathy Management
Exploring risk factors and promising new treatments might slow the progression of diabetic retinopathy. Medscape Medical News
Vision Loss a Dementia Risk Factor? What Do the Data Say?
A recent Lancet report claims nearly half of dementia cases could be prevented by addressing 14 risk factors, including vision loss. But is this recommendation backed by evidence? Let’s explore Medscape Medical News
Disclose Ethics Consult to Patients? Ethicist Weighs In
Ethicist Art Caplan discusses whether doctors need to disclose ethics consults to patients or families. Medscape Business of Medicine
Dementia Deemed Highly Preventable: Here’s How
Newly identified modifiable risk factors add to what we already know about preventing or delaying dementia. Medscape Ob/Gyn
What ‘Project 2025’ Would Mean for Health and Healthcare
Excerpts from Project 2025 demonstrate the likely impact of sweeping changes to US healthcare policy. Medscape Internal Medicine
Xanthelasma Not Linked to Heart Diseases, Study Finds
Cholesterol deposits over the eyelids were not associated with an increased prevalence of lipid abnormalities or cardiovascular risk in a new study. Medscape Medical News
Study Highlights Antibiotics Linked to Severe Skin Reactions
Compared with macrolides, sulfonamides were most strongly associated with serious cutaneous reactions. Medscape Medical News
Retinal Treatments Don’t Just Cost the Price on the Package
Ophthalmologists need more wiggle room from insurers to determine the best treatment for their patients based on a drug’s cost, its expected impact, and the person’s circumstances. Medscape Medical News
AI Can Detect Pediatric Eye Diseases From Mobile Photographs
AI offered effective screening for three common eye diseases in children and adolescents using smartphone images taken at home. Medscape Medical News
Higher Uveitis Risk in Cancer Patients on BRAF Inhibitors
BRAF inhibitors raise the risk for uveitis in patients with skin melanoma or lung cancer compared with conventional cytotoxic drugs or immune checkpoint inhibitors. Medscape Medical News
Why No Federal Ban on Copay Accumulators and Maximizers?
The US federal government refrains from enforcing bans on copay accumulators and maximizers for the American public, but it does ban them in its plan for federal workers. Why the double standard? Medscape Rheumatology
Sex, Marriage, Race, Education: 18 Years of Life Expectancy
Can a simple scoring system predict risk for death? Dr F. Perry Wilson discusses. Medscape
Monoclonal Antibodies Make Headway in Sjögren Treatment
Positive results were reported from the DAHLIAS study of nipocalimab, the TWINSS study of iscalimab, and a phase 1 trial of tibulizumab, but it was negative news for lusvertikimab. Medscape Medical News
New Drugs Could Reduce AMD Treatment Burden
Emerging predictive tools and novel therapeutic approaches could reduce eye injections for patients with dry and wet age-related macular degeneration. Medscape Medical News
Understanding Sudden Unexpected Death in Epilepsy
Learn more about SUDEP, its risk factors, and the importance of epilepsy awareness and management. WebMD
Insurers’ Preauthorization Rules “Ethically Nuts”: Ethicist
Ethicist Art Caplan discusses the ethics of insurers’ rules and use of artificial intelligence in preauthorizing patients’ medical treatment. Medscape Business of Medicine